Chris Picardo

Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020.